An interventional study of Novel Internal Fixation Nerve Block Catheter - Sciatic Nerve and Novel Internal Fixation Nerve Block Catheter - Saphenous nerve in Primary Condition: Nerve Block, Secondary Condition: Catheter Displacement and Focus of Study: Sciatic Nerve, sponsored by Nordsjaellands Hospital. Not yet recruiting at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-02-04.
Sponsored by Nordsjaellands Hospital · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The goal of this study is to test a new type of nerve block catheter (a thin, flexible tube used to deliver pain medication). Researchers want to see if this new design stays in its original position better than current catheters and if it is easy for doctors to use.
The main questions the study aims to answer are:
Does the catheter tip stay in the correct position over time without moving or slipping (dislocation)?
Can the catheter be placed quickly and accurately using the new deployment system?
Researchers will test this prototype in a small group of participants. There is no comparison group for this initial study.
Participants will:
Have the catheter placed near a nerve in their leg a few days before a scheduled femoral (leg) amputation.
Undergo imaging or checks to see if the catheter has moved.
Have the catheter removed just before their scheduled surgery.
The catheter will be placed in an area of the leg that is already scheduled to be removed during surgery. This ensures that the study carries minimal risk to the participants.
Background and Rationale Peripheral nerve blocks are a standard of care for regional anesthesia; however, traditional catheters are prone to secondary dislocation (slipping out of place), which leads to inadequate pain control. This study evaluates a novel prototype catheter designed with an internal fixation mechanism intended to secure the catheter tip at the target site. Additionally, the system utilizes a refined deployment mechanism designed for rapid and precise placement by the clinician.
Study Objective The primary objective of this pilot study is to evaluate the stability and migration rate of the catheter tip over a multi-day period. Secondarily, the study will assess the technical feasibility and speed of the deployment system.
Study Design and Safety Model This is a single-arm, non-randomized, proof-of-concept trial. To ensure maximum participant safety during the testing of this new hardware, the study utilizes a femoral amputation model.
The catheter will be placed in participants who are already scheduled for a femoral amputation. The insertion site and the final position of the catheter tip will be located distal to (below) the anticipated surgical amputation line. This ensures that the tissue involved in the study is part of the limb intended for removal, thereby minimizing any long-term risk of nerve injury or local tissue complications for the participant.
Procedures
Baseline \& Placement: Eligible participants will have the prototype catheter placed via ultrasound guidance several days prior to their scheduled surgery. The time required for deployment will be recorded.
Monitoring Period: The position of the catheter tip will be monitored at set intervals using ultrasound imaging to track any migration or dislocation from the initial placement site.
Removal: The catheter will be removed in the operating room immediately prior to the commencement of the scheduled amputation.
Nordsjaellands Hospital is the lead sponsor of 89 studies on the registry; 19 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
All participants will receive the prototype fixation catheter placed near the sciatic nerve distal to the planned amputation line.
Device: Novel Internal Fixation Nerve Block Catheter - Sciatic Nerve
If the planned amputation line is high enough on the femur to allow for distal placement, participants will also receive a second prototype fixation catheter near the saphenous nerve.
Device: Novel Internal Fixation Nerve Block Catheter - Saphenous nerve
A peripheral nerve block catheter prototype featuring internal fixation to prevent dislocation and a rapid-deployment system. Catheters are placed under ultrasound guidance.
Placement of the saphenous catheter is contingent upon an amputation line that allows for placement below the surgical site (distal to the cut).
Catheter Dislocation Distance
The absolute distance (in millimeters) between the position of the catheter delivery orifice at initial placement and its position just before removal. The position is verified by ultrasound imaging using hydrodissection with a local anesthetic bolus to identify the orifice.
Time frame: From initial placement (Day 0) to immediately prior to amputation surgery (typically 48-72 hours).
Time on Task
Time required for catheter placement, measured from initiation of skin disinfection to final skin fixation using a stopwatch (seconds).
Time frame: At time of procedure (Day 0)
Primary Placement Success Rate
Proportion of successful primary catheter placements, defined as the accurate position of the delivery orifice verified by ultrasound
Time frame: At time of procedure (Day 0)
Catheter Clinical Performance (Sensory Block)
Sensitivity to a cooled vial (5°C) over the cutaneous innervation area (Tibial/Peroneal for sciatic; Saphenous for saphenous nerve).
Time frame: Day 0 (preprocedure and postprocedure), day 1, day 2, and day 3.
Catheter Retraction Force
The force required for catheter removal, measured with a digital handheld force transducer (Newtons).
Time frame: Day 3 (just before surgery)
Pain Intensity (NRS)
Participant-reported pain at rest using a Numeric Rating Scale (0-10, where 0 is no pain and 10 the worst thinkable pain)
Time frame: Day 0, Day 1, Day 2 and Day 3
Cumulative Opioid Consumption
Total intravenous (IV) morphine equivalents administered while the catheter is in place.
Time frame: Day 0 to day 3 (Entire study duration)
Incidence of Adverse Events
Number and nature of complications including infection, back-leakage, or device-related issues.
Time frame: Day 0 to day 3 (Entire study duration)
Plan to share: Undecided — Whether individual participant data will be shared has not yet been determined. The study evaluates novel design principles and mechanical fixation mechanisms for which intellectual property (IP) protection is currently being sought or finalized. A decision regarding the sharing of de-identified data will be made once the proprietary interests of the device design are fully secured and the primary feasibility analysis is complete.
Start is estimated for Feb 2026; primary completion for Aug 2026, 6 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Nordsjaellands Hospital